Breaking News - The Fly

Open Search

EFTR

eFfector Therapeutics

$

()

eFFECTOR Therapeutics trading resumes

EFTR

4/4/2024 - 09:00am

eFfector sees no 'obvious' path forward for tomivosertib development in NSCLC

EFTR

4/4/2024 - 08:43am

eFFECTOR Therapeutics trading halted, news pending

EFTR

4/4/2024 - 08:25am

Fly Intel: After-Hours Movers

STOK , APPF , NARI

…

3/25/2024 - 19:44pm

eFfector Therapeutics reports Q4 EPS ($3.42), consensus ($1.65)

EFTR

3/25/2024 - 16:10pm

eFfector Therapeutics target adjusted to $24 at H.C. Wainwright

EFTR

2/6/2024 - 09:54am

eFfector to sell 1.49M shares at $10.075 in registered direct offering

EFTR

1/25/2024 - 08:14am

eFfector Therapeutics to hold a virtual investor meeting

EFTR

1/24/2024 - 16:15pm

eFfector Therapeutics to hold a virtual investor meeting

EFTR

1/24/2024 - 04:55am

eFfector Therapeutics to hold a virtual investor meeting

EFTR

1/20/2024 - 16:48pm

eFFECTOR Therapeutics trading halted, news pending

EFTR

1/11/2024 - 19:50pm

eFfector Therapeutics board approves 1-for-25 reverse stock split

EFTR

1/9/2024 - 08:06am

eFfector announces interim data from Phase 2 expansion cohorts of zotatifin

EFTR

12/8/2023 - 08:19am

eFFECTOR Therapeutics receives Fast Track Designation for zotatifin combination

EFTR

11/28/2023 - 08:03am

eFfector Therapeutics reports Q3 EPS (13c), consensus (12c)

EFTR

11/13/2023 - 16:55pm